IOL Chemicals and Pharmaceuticals net profit grows 32 Percentage YoY

Press Release

20 Oct 2023

  • Total income for Q1 FY24 stood at Rs. 570 crore at the same level of Rs.570 crore YoY
  • EBITDA for Q1 FY24 at Rs. 80 crore as compared to Rs. 61 crore YoY
  • Net profit for Q1 FY24 at Rs. 46 crore as compared to Rs. 35 crore YoY

10th August 2023, New Delhi:
IOL Chemicals and Pharmaceuticals Ltd, a leading manufacturer of pharmaceutical APIs and speciality chemicals, announced its financial results for the first quarter ended June 30, 2023.

Q1FY24 Financial Highlights
(Rs in Crore)
Particulars Q1FY24 Q1FY23 % YoY Q4FY23
Total Income 570.24 570.16 - 595.93
EBITDA 79.92 61.17 30.6 % 104.51
EBITDA Margin (%) 14.0% 10.7% 330 bps 17.5 %
PAT 46.21 34.89 32.4% 65.27
PAT Margin (%) 8.1% 6.1% 200 bps 11.0%

Commenting on the performance, Mr Vikas Gupta, Joint Managing Director, said “We are pleased to report sustainable performance during the 1st quarter of FY24, tackling present challenges while positioning ourselves for forthcoming opportunities. We are hopeful for increased presence in regulatory market as the Company got CEP for paracetamol. Additionally, with the commencement of Acetic Anhydride plant, focus on improved efficiencies, product mix and timely execution we are hopeful to generate strong cash flow”.

News Articles More

Contact Now
Have a question or feedback, let us know!

Please enter the string as shown above: